Chief Technology Officer
Lijun Wang is the Co-founder and Chief Technology Officer of Exegenesis Bio Inc. She has more than 20 years’ experience and deep understanding of biologics process development and GMP manufacturing, with extensive focus on gene therapy viral vectors manufacturing and viral vector facility design.
Prior to the current role, she served as Director of Process Development and Manufacturing at Encoded Therapeutics (2018-2019). She fulfilled multiple key process development and manufacturing roles at Brammer Bio (2009-2018, previously Florida Biologix), including Director of Drug Substance Manufacturing, responsible for phase I-III CTM manufacturing.
Prior to CDMO experience, Lijun started her gene therapy journey at AGTC, a clinical-stage company, responsible for downstream process establishment and tech transfer of multiple AAV processes (2006-2009).
She received her Master’s in Chemistry from University of Kansas and B.S. in Biochemical Engineering from East-China University of Science and Technology.